SUBSCRIBE
SUBSCRIBE

Acambis Files ‘First-Ever’ BLA: Arilvax Vaccine In Yellow Fever

October 19, 2005 | 
1 min read

Acambis plc filed a biologics license application seeking approval of Arilvax as a vaccine to prevent yellow fever.

Europe
MORE ON THIS TOPIC
Fund raising Capital Donation. Funds Support Concept. Fundraising. Collecting donations in jar.
Funding
Novo Foundation Pumps $850M Into Denmark, Europe to Bolster Innovation
January 16, 2026
 · 
2 min read
 · 
Tristan Manalac
Collage image depicting brainstorming to get around obstacle/resistance
Job Trends
3 Top Challenges Facing Manufacturing Professionals Right Now
January 15, 2026
 · 
6 min read
 · 
Angela Gabriel
Acadia CEO Catherine Owen Adams,
Policy
Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech
January 13, 2026
 · 
3 min read
 · 
Annalee Armstrong
Photo of Basel, Switzerland, and Rhine river
Business
Basel Life Sciences Scene Embraces International Companies, Startups
November 6, 2025
 · 
6 min read
 · 
Angela Gabriel